{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/61a635a4106ee100125850bb/64e731b958387d00112b4503?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Molecular Tumour Board","description":"<p>Our guests today include Dr Dearbhaile Collins, Tanya Knott and Claire Bermingham. Dearbhaile</p><p>Colllins is a medical oncologist, and also the Clinical Lead for the Cancer Trials Ireland Molecular</p><p>Tumour Board.</p><p><br></p><p>Tanya Knott represents patients on the Molecular Tumour Board steering committee. She’s also a</p><p>Director of the SJK Foundation, which was founded in honour of Tanya’s sister Sarah Jennifer Knott,</p><p>who died of CUP, Cancer of Unknown Primary, aged 31.</p><p><br></p><p>Our last guest is Claire Bermingham, who co-ordinates the Molecular Tumour Board in Cancer Trials</p><p>Ireland.</p><p><br></p><p>THINGS WE SPOKE ABOUT</p><p><br></p><ul><li>How the MTB works and success with patients</li><li>Next Generation Sequencing</li><li>The cost of going private</li><li>Sarah Jennifer Knotts story and the work of the foundation</li><li>How doctors can have MTB review cases</li></ul><p><br></p><p>MORE INFORMATION</p><p><br></p><p>https://sjkfoundation.org/about-us/</p><p>https://www.cancertrials.ie/molecular-tumor-board/</p>","author_name":"Cancer Trials Ireland"}